Patent · US Active

Phage-derived particles for in situ delivery of DNA payload into C. acnes population

US11820989B2 · kind B2 · utility

0Cited by
0References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 4, 2021
Grant dateNov 21, 2023
Priority date
Expiry dateNov 18, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC40B40/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to C. acnes carrying DNA vectors with a C. acnes phage packaging signal and a gene of interest. The invention encompasses a C. acnes producer cell carrying DNA vectors, with a C. acnes phage packaging signal and a gene of interest, for the production of phage-derived particles that can robustly transduce C. acnes receiver cell allowing transgene expression. The invention encompasses C. acnes phage-derived particles carrying these vectors, C. acnes containing these vectors or modified by transduction of these phage-derived particles, and methods of using these phage-derived particles.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.